CVS Stock Ownership Activity

CVS HEALTH CORP 13F holders

4 value investing gurus have made changes to the CVS HEALTH CORP (CVS) position according to the gurus' latest SEC quarterly report(s). CVS has been bought (as a new position) by 1 guru(s), the number of CVS shares has been increased by 2, decreased by 1 super investor(s).

Which gurus or hedge funds are buying CVS now?

According to the latest SEC filing(s) CVS HEALTH CORP (CVS) has been bought by 3 gurus: V. D. Dodge, E. M. Cox - Dodge & Cox Stock Fund (added shares +0.19%), Andrew Brenton - Turtle Creek Asset Management (new buy) and Ronald Muhlenkamp - Muhlenkamp & Co (added shares +0.11%).

To see more about who is investing in CVS HEALTH CORP (CVS), please go to the CVS ownership page.

2022 Q4 (1 result)
Ronald Muhlenkamp
+0.11%
+122
+0.00%
4.35%
Current price: $87.49 6.12% Reported price*: $93.19
2022 Q3 (4 results)
Andrew Brenton
buy
+1,400
+0.01%
0.01%
Ronald Muhlenkamp
+0.99%
+1,078
+0.05%
4.68%
V. D. Dodge, E. M. Cox
+0.19%
+17,000
+0.00%
1.13%
David Katz
-15.97%
-3,800
-0.74%
3.92%
Current price: $87.49 8.35% AVG reported price*: $95.46
2022 Q2 (4 results)
Ronald Muhlenkamp
-0.10%
-114
-0.00%
4.73%
V. D. Dodge, E. M. Cox
-1.32%
-122,700
-0.01%
1.02%
Robert Olstein
-23.23%
-23,000
-0.32%
1.06%
Prem Watsa
-43.40%
-11,500
-0.04%
0.05%
Current price: $87.49 5.58% AVG reported price*: $92.66
2022 Q1 (4 results)
Ronald Muhlenkamp
+0.37%
+404
+0.01%
3.84%
David Katz
-13.77%
-3,800
-0.58%
3.65%
Mark A. Hillman
-15.58%
-12,000
-0.49%
2.67%
Robert Olstein
-21.43%
-27,000
-0.34%
1.26%
Current price: $87.49 13.56% AVG reported price*: $101.21
2021 Q4 (5 results)
Ronald Muhlenkamp
-0.01%
-12
-0.00%
3.91%
V. D. Dodge, E. M. Cox
-4.43%
-431,000
-0.05%
1.00%
David Katz
-4.83%
-1,400
-0.21%
4.04%
Robert Olstein
-28.81%
-51,000
-0.63%
1.55%
Michael Burry
-100.00%
-200,000
-22.79%
0.00%
Current price: $87.49 15.19% AVG reported price*: $103.16
2021 Q3 (3 results)
Ronald Muhlenkamp
-0.17%
-189
-0.01%
3.54%
Robert Olstein
-1.67%
-3,000
-0.03%
1.84%
James Crichton
-100.00%
-360,000
-1.05%
0.00%
Current price: $87.49 3.10% AVG reported price*: $84.86
2021 Q2 (5 results)
James Crichton
buy
+360,000
+1.01%
0.00%
Michael Burry
+81.82%
+90,000
+5.46%
12.13%
Ronald Muhlenkamp
+0.17%
+189
+0.01%
3.33%
Bruce Berkowitz
-100.00%
-147,000
-0.87%
0.00%
C.T. Fitzpatrick
-100.00%
-8,751
-0.00%
0.00%
Current price: $87.49 4.85% AVG reported price*: $83.44
2021 Q1 (8 results)
Michael Burry
buy
+110,000
+7.11%
7.11%
Bruce Berkowitz
+32.31%
+35,900
+0.22%
0.00%
Mark A. Hillman
+22.22%
+14,000
+0.61%
3.35%
Robert Olstein
+6.51%
+11,000
+0.12%
1.89%
V. D. Dodge, E. M. Cox
+4.95%
+459,600
+0.04%
0.93%
Ronald Muhlenkamp
+0.31%
+334
+0.01%
3.48%
C.T. Fitzpatrick
-99.73%
-3,221,594
-1.43%
0.00%
Bill Miller
-100.00%
-1,899
-0.00%
0.00%
Current price: $87.49 13.87% AVG reported price*: $76.83
2020 Q4 (8 results)
Bruce Berkowitz
buy
+111,100
+0.61%
0.61%
Bill Miller
+40.15%
+544
+0.00%
0.00%
Mark A. Hillman
+26.00%
+13,000
+0.67%
3.26%
C.T. Fitzpatrick
+5.85%
+178,500
+0.08%
1.43%
V. D. Dodge, E. M. Cox
+3.31%
+297,600
+0.03%
0.90%
Robert Olstein
+1.20%
+2,000
+0.02%
1.84%
Ronald Muhlenkamp
+0.79%
+852
+0.02%
2.98%
Michael Burry
-100.00%
-150,000
-6.26%
0.00%
Current price: $87.49 28.05% AVG reported price*: $68.32
2020 Q3 (6 results)
Bill Miller
buy
+1,355
+0.00%
0.00%
Michael Burry
buy
+150,000
+5.68%
0.00%
Mark A. Hillman
+25.00%
+10,000
+0.56%
2.81%
Robert Olstein
+15.97%
+23,000
+0.24%
1.77%
Ronald Muhlenkamp
+0.86%
+911
+0.03%
3.25%
C.T. Fitzpatrick
-30.39%
-1,332,165
-0.61%
1.39%
Current price: $87.49 49.85% AVG reported price*: $58.38
48 of 123

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.